Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in Advanced/Metastatic Liposarcoma
NCT01692496Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Jan 2013
- Primary completion
- Mar 2018
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of pazopanib in Liposarcoma, sponsored by Spanish Group for Research on Sarcoma. Started Jan 2013; status: completed.
02
Drugs
pazopanib
03
Conditions
Liposarcoma
Beyond the preview
Go deeper on NCT01692496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01692496.